🇺🇸 Synvisc-One in United States

80 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 80

Most-reported reactions

1. Pain — 16 reports (20%)
2. Arthralgia — 11 reports (13.75%)
3. Osteoarthritis — 8 reports (10%)
4. Pain In Extremity — 8 reports (10%)
5. Fatigue — 7 reports (8.75%)
6. Diarrhoea — 6 reports (7.5%)
7. Drug Hypersensitivity — 6 reports (7.5%)
8. Ill-Defined Disorder — 6 reports (7.5%)
9. Joint Swelling — 6 reports (7.5%)
10. Nausea — 6 reports (7.5%)

Source database →

Frequently asked questions

Is Synvisc-One approved in United States?

Synvisc-One does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Synvisc-One in United States?

Nature Cell Co. Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.